Peter Haytko
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Bone health and treatments
Papers in
-
- Glycosylation and Glycoproteins Research 3
- RNA Interference and Gene Delivery 2
- Bone Metabolism and Diseases 1
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Mark L. Chiu (6 shared papers)Paul W.H.I. Parren (3 shared papers)Barbara S. Bushey (3 shared papers)Joost Neijssen (3 shared papers)Janine Schuurman (3 shared papers)Matthew V. Lorenzi (2 shared papers)Kristen Chevalier (3 shared papers)Sheri L. Moores (3 shared papers)
- Journals
- Cancer Research (3 papers)Assay and Drug Development Technologies (1 paper)Pharmaceutics (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)mAbs (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Peter Haytko
9 papers receiving 356 citations
Peers
Comparison fields: 5 of 51
- Radiology, Nuclear Medicine and Imaging 153
- Oncology 173
- Immunology 78
- Orthopedics and Sports Medicine 29
- Molecular Biology 226
Countries citing papers authored by Peter Haytko
This map shows the geographic impact of Peter Haytko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Haytko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Haytko more than expected).
Fields of papers citing papers by Peter Haytko
This network shows the impact of papers produced by Peter Haytko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Haytko. The network helps show where Peter Haytko may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Haytko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 188 | |
| 2 | 2009 | 75 | |
| 3 | 2011 | 71 | |
| 4 | 2016 | 18 | |
| 5 | 2005 | 15 | |
| 6 | 2013 | 2 | |
| 7 | 2025 | 1 | |
| 8 | 2025 | 1 | |
| 9 | 2014 | 1 |
About Peter Haytko
Peter Haytko is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 9 papers that have together received 372 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Lung Cancer Treatments and Mutations (2 papers), RNA Interference and Gene Delivery (2 papers), CAR-T cell therapy research (1 paper), Bone health and osteoporosis research (1 paper) and Bone Metabolism and Diseases (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (153 citations), Oncology (173 citations), Immunology (78 citations), Orthopedics and Sports Medicine (29 citations) and Molecular Biology (226 citations). Peter Haytko has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Mark L. Chiu, Paul W.H.I. Parren, Barbara S. Bushey, Joost Neijssen, Janine Schuurman, Matthew V. Lorenzi, Kristen Chevalier, Sheri L. Moores, Ricardo M. Attar and Pauline L. Martin. Their work appears in journals such as Cancer Research, Assay and Drug Development Technologies, Pharmaceutics, Journal of Pharmacology and Experimental Therapeutics and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.